(R)-SL18
(R)-SL18 is an annexin A3 (ANXA3) degrader with a Kd value of 1.15 μM for human ANXA3. (R)-SL18 induces ANXA3 degradation via the ubiquitination pathway, shows poor degradation selectivity among annexin family proteins, and its moderate ANXA3 binding affinity correlates with off-target effects. (R)-SL18 inhibits the proliferation, migration, invasion and colony formation of cancer cells. (R)-SL18 can be used in the research of triple-negative breast cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3023189-40-1
- Formel: C26H21ClN6O5S2
- Molecular Weight:597.07
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
AnxA3 1.15 μM (Kd) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-468 | IC50 |
2.45 μM
|
Antiproliferative activity against human MDA-MB-468 triple-negative breast cancer cells assessed via cell proliferation inhibition assay.
Antiproliferative activity against human MDA-MB-468 triple-negative breast cancer cells assessed via cell proliferation inhibition assay.
|
40013713 |
| MDA-MB-231 | IC50 |
3.53 μM
|
Antiproliferative activity against human MDA-MB-231 triple-negative breast cancer cells assessed via cell proliferation inhibition assay.
Antiproliferative activity against human MDA-MB-231 triple-negative breast cancer cells assessed via cell proliferation inhibition assay.
|
40013713 |
In Vitro
(R)-SL18 binds to purified ANXA3 protein with a Kd of 1.15 μM[1].
(R)-SL18 inhibits proliferation of MDA-MB-468 TNBC cells with an IC50 of 2.45 μM[1].
(R)-SL18 inhibits proliferation of MDA-MB-231 TNBC cells with an IC50 of 3.53 μM[1].
(R)-SL18 (0.25-1.0 μM μM; 24 h) reduces migration of MDA-MB-468 TNBC cells by 52-62%[1].
(R)-SL18 (0.625-2.5 μM; 24 h) reduces migration of MDA-MB-231 TNBC cells by 46-51% at 0.625 μM, 82-87% at 1.25 μM, and 93-95% at 2.5 μM after 24 h of treatment[1].
(R)-SL18 (0.25-1.0 μM) reduces invasion of MDA-MB-468 TNBC cells by 13-19% at low concentration, 24-35% at medium concentration, and 47-61% at high concentration[1].
(R)-SL18 (0.625-2.5 μM) reduces invasion of MDA-MB-231 TNBC cells by 23-31% at low concentration, 31-42% at medium concentration, and 71-76% at high concentration[1].
(R)-SL18 (0.25-1.0 μM; 14-21 days) reduces colony formation of MDA-MB-468 TNBC cells by 12-24% at low concentration, 26-35% at medium concentration, and 49-52% at high concentration over 14-21 days with redosing every 3 days[1].
(R)-SL18 (0.625-2.5 μM; 14-21 days) reduces colony formation of MDA-MB-231 TNBC cells by 2-23% at low concentration, 33-38% at medium concentration, and 60-68% at high concentration over 14-21 days with redosing every 3 days[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB-468 TNBC cells
-
Concentration:0.25 μM; 0.5 μM; 1 μM
-
Incubation Time:24 h
-
Result:Reduced migration ability of MDA-MB-468 cells by 52-62%.
-
Cell Line:MDA-MB-231 TNBC cells
-
Concentration:0.625 μM; 1.25 μM; 2.5 μM
-
Incubation Time:24 h
-
Result:Reduced migration ability of MDA-MB-231 cells by 46-51% at 0.625 μM.
Reduced migration ability of MDA-MB-231 cells by 82-87% at 1.25 μM.
Reduced migration ability of MDA-MB-231 cells by 93-95% at 2.5 μM.
-
Cell Line:MDA-MB-468 TNBC cells
-
Concentration:0.25 μM; 0.5 μM; 1 μM
-
Incubation Time:14-21 days
-
Result:Reduced the colony formation rate of MDA-MB-468 triple-negative breast cancer (TNBC) cells: a 12-24% reduction in the low-concentration group, a 26-35% reduction in the medium-concentration group, and a 49-52% reduction in the high-concentration group.
-
Cell Line:MDA-MB-231 TNBC cells
-
Concentration:0.625 μM; 1.25 μM; 2.5 μM
-
Incubation Time:14-21 days
-
Result:Reduced the colony formation rate of MDA-MB-231 triple-negative breast cancer (TNBC) cells: 2-23% reduction in the low-concentration group, 33-38% reduction in the medium-concentration group, and 60-68% reduction in the high-concentration group.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/C nude (female, 4-6 weeks of age)[1]
-
Dosage:20 mg/kg
-
Administration:i.p.; daily; 21 days
-
Result:Had antitumor activity in a xenograft model of triple-negative breast cancer (TNBC).
Chemical Information
-
CAS. Nr. 3023189-40-1
-
Molecular Weight 597.07
-
Formel C26H21ClN6O5S2
-
SMILES
CN1C2=CC=CC=C2C(C3=CC=CC=C3)=N[C@@H](NC(SCC(NC(NC4=CC(Cl)=CC=C4[N+]([O-])=O)=O)=O)=S)C1=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)